 |
BioWorld-International-2009-02-18
NeuroSearch in Blockbuster Ion Channel Deal with Lilly
NeuroSearch in Blockbuster Ion Channel Deal with Lilly
NeuroSearch A/S shrugged off disappointment in the clinic last week - namely, the failure of ABT-894 in a Phase II trial in diabetic neuropathic pain - with a three-year central nervous system drug discovery alliance with Eli Lilly and Co. that has the potential to grow to blockbuster proportions.
Novelos, Mundipharma Sign $95M Deal for Cancer Drug
Novelos Therapeutics Inc. has signed a $95 million deal with Mundipharma International Corp. Ltd. to market a cancer drug in Europe and Japan, with $10 million of that paid up front by Purdue Pharma LP, an independent company associated with the UK firm. (BioWorld International)